![Robert A. Shalwitz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert A. Shalwitz
Fondatore presso Invirsa, Inc.
Posizioni attive di Robert A. Shalwitz
Società | Posizione | Inizio | Fine |
---|---|---|---|
Invirsa, Inc.
![]() Invirsa, Inc. Medical/Nursing ServicesHealth Services Invirsa, Inc. provides medical services. The company was founded by Robert Shalwitz on November 24, 2014 and is headquartered in Bexley, OH. | Direttore/Membro del Consiglio | 24/11/2014 | - |
Amministratore Delegato | 24/11/2014 | - | |
Fondatore | 24/11/2014 | - | |
Presidente | 24/11/2014 | - |
Storia della carriera di Robert A. Shalwitz
Precedenti posizioni note di Robert A. Shalwitz
Società | Posizione | Inizio | Fine |
---|---|---|---|
AKEBIA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 07/01/2014 | 05/08/2014 |
Fondatore | 27/02/2007 | 31/12/2014 | |
Corporate Officer/Principal | 05/08/2014 | 31/12/2014 | |
Vendite & Marketing | 27/02/2007 | 07/01/2014 | |
Heart Metabolics Ltd.
![]() Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Direttore operativo | 15/03/2016 | - |
Aerpio Therapeutics, Inc.
![]() Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Direttore Tecnico/Scientifico/R&S | 01/01/2011 | - |
Fondatore | 01/01/2011 | - | |
ABBOTT LABORATORIES | Direttore Tecnico/Scientifico/R&S | - | - |
Reliant Pharmaceuticals LLC
![]() Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Direttore Tecnico/Scientifico/R&S | 01/01/2005 | - |
Formazione di Robert A. Shalwitz
University of Michigan | Undergraduate Degree |
State University of New York at Buffalo | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Irlanda | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Founder | 3 |
Corporate Officer/Principal | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
AKEBIA THERAPEUTICS, INC. | Health Technology |
ABBOTT LABORATORIES | Health Technology |
Aziende private | 4 |
---|---|
Reliant Pharmaceuticals LLC
![]() Reliant Pharmaceuticals LLC Miscellaneous Commercial ServicesCommercial Services Reliant Pharmaceuticals, Inc. sells, markets and develops cardiovascular pharmaceutical products. The company focuses on marketing promotionally sensitive pharmaceutical products to the primary care, cardiovascular and specialist physician markets in the United States. The company is headquartered in Liberty Corner, NJ | Commercial Services |
Aerpio Therapeutics, Inc.
![]() Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Health Technology |
Heart Metabolics Ltd.
![]() Heart Metabolics Ltd. BiotechnologyHealth Technology Heart Metabolics Ltd. operates as a biopharmaceutical company that engages in developing new treatments for orphan disease including cardio-metabolic diseases. The firm provides drugs to treat heart failure for hypertrophic cardiomyopathy patients. The company was founded by Michael Paul Frenneaux and Houshman Ashrafian in 2004 and is headquartered in Dublin, Ireland. | Health Technology |
Invirsa, Inc.
![]() Invirsa, Inc. Medical/Nursing ServicesHealth Services Invirsa, Inc. provides medical services. The company was founded by Robert Shalwitz on November 24, 2014 and is headquartered in Bexley, OH. | Health Services |
- Borsa valori
- Insiders
- Robert A. Shalwitz
- Esperienza